Literature DB >> 21788903

Repeat partial nephrectomy: surgical, functional and oncological outcomes.

Brian Shuch1, W Marston Linehan, Gennady Bratslavsky.   

Abstract

PURPOSE OF REVIEW: The greater utilization of partial nephrectomy and ablative procedures has increased the incidence of patients presenting with local renal recurrence. The choice to either perform a partial or radical nephrectomy in these situations can be a challenging decision. RECENT
FINDINGS: Repeat and salvage partial nephrectomy, while challenging and potentially associated with increased complications, offers patients the ability to maintain excellent renal functional outcomes and promising oncologic outcomes at intermediate follow-up.
SUMMARY: Surgeons should be familiar with the surgical complications and the functional and oncologic outcomes of reoperative nephron-sparing surgery (NSS). Recent data and outcome analysis support utilization of these procedures in patients presenting with either local recurrence or de-novo lesions in the ipsilateral kidney.

Entities:  

Mesh:

Year:  2011        PMID: 21788903      PMCID: PMC3173810          DOI: 10.1097/MOU.0b013e32834964ea

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  63 in total

1.  Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?

Authors:  Brian R Lane; Amr F Fergany; W Marston Linehan; Gennady Bratslavsky
Journal:  Urology       Date:  2010-09       Impact factor: 2.649

Review 2.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

3.  Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma.

Authors:  Jean-Christophe Bernhard; Allan J Pantuck; Hervé Wallerand; Maxime Crepel; Jean-Marie Ferrière; Laurent Bellec; Sylvie Maurice-Tison; Grégoire Robert; Baptiste Albouy; Gilles Pasticier; Michel Soulie; David Lopes; Bertrand Lacroix; Karim Bensalah; Christian Pfister; Rodolphe Thuret; Jacques Tostain; Alexandre De La Taille; Laurent Salomon; Clément Abbou; Marc Colombel; Arie S Belldegrun; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2010-02-19       Impact factor: 20.096

4.  Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.

Authors:  Igor Frank; Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

5.  Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy.

Authors:  Rodney H Breau; Paul L Crispen; Rafael E Jimenez; Christine M Lohse; Michael L Blute; Bradley C Leibovich
Journal:  J Urol       Date:  2010-01-18       Impact factor: 7.450

6.  Feasibility of laparoscopic partial nephrectomy after previous ipsilateral renal procedures.

Authors:  Burak Turna; Monish Aron; Rodrigo Frota; Mihir M Desai; Jihad Kaouk; Inderbir S Gill
Journal:  Urology       Date:  2008-06-24       Impact factor: 2.649

7.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.

Authors:  Keith J Kowalczyk; H Brooks Hooper; W Marston Linehan; Peter A Pinto; Bradford J Wood; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

9.  Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant.

Authors:  James S Magera; Igor Frank; Christine M Lohse; Bradley C Leibovich; John C Cheville; Michael L Blute
Journal:  J Urol       Date:  2008-01-25       Impact factor: 7.450

10.  Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery.

Authors:  Vassilis Poulakis; Ulrich Witzsch; Rachelle de Vries; Matthias Moeckel; Eduard Becht
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

View more
  5 in total

Review 1.  The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma.

Authors:  Leonardo D Borregales; Mehrad Adibi; Arun Z Thomas; Christopher G Wood; Jose A Karam
Journal:  Ther Adv Urol       Date:  2015-11-20

2.  Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma.

Authors:  O A Voylenko; O E Stakhovsky; I V Vitruk; O A Kononenko; M V Pikul; S L Semko; E O Stakhovsky
Journal:  Adv Urol       Date:  2021-04-30

3.  Oncological and functional outcomes of salvage renal surgery following failed primary intervention for renal cell carcinoma.

Authors:  Fernando G Abarzua-Cabezas; Einar Sverrisson; Robert De La Cruz; Philippe E Spiess; Peter Haddock; Wade J Sexton
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

4.  Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma.

Authors:  Martin Lang; Cathy D Vocke; Christopher J Ricketts; Adam R Metwalli; Mark W Ball; Laura S Schmidt; William M Linehan
Journal:  Urology       Date:  2020-11-24       Impact factor: 2.649

5.  Outlining the limits of partial nephrectomy.

Authors:  Sameer Chopra; Raj Satkunasivam; Chandan Kundavaram; Gangning Liang; Inderbir S Gill
Journal:  Transl Androl Urol       Date:  2015-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.